Year: 2008

(3 stars)
This story reports on studies of a drug for aggressive prostate cancer. It overstates the importance of early research, garbles the findings, and exaggerates the benefits.

(4 stars)
In the space of less than 600 words, this story meets most of the criteria for a well constructed and objective report.

(2 stars)
Until there is evidence of high surgery rates from more clinics and solid evidence that these operations are caused by over-training, this article could be raising unfounded alarm.

(2 stars)
Vytorin is hot news.  But patients, let alone stock market speculators, would be better served by a more informative analysis than that provided in this business-oriented story.

(5 stars)
This article summarizes a recent research study comparing the long-term effects of three popular diets. It was accurate, balanced, reliable, and well written.

Screening could work best for early-stage patients who don’t yet need dialysis, study says.
Source: HealthDay

Study finds despite hazards, many put themselves at increased risk for second malignancies.
Source: HealthDay

But some researchers say the finding fails to establish cause-and-effect.
Source: HealthDay

Source: National Institute on Drug Abuse

Source: Food and Drug Administration

Findings could lead to new therapies to prevent nicotine craving.
Source: HealthDay

The hope is they will be a better match than last year’s shots.
Source: HealthDay